Question 1

What is TherapeuticsMD?

Accepted Answer

TherapeuticsMD is a Company.

Question 2

How often does TherapeuticsMD appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was TherapeuticsMD first tracked by Ergen?

Accepted Answer

First tracked on Jun 09, 2026.

Question 4

When was TherapeuticsMD last mentioned in news?

Accepted Answer

Last active on Jun 17, 2026.

Question 5

What is TherapeuticsMD's current news sentiment?

Accepted Answer

Aggregate sentiment score: 40 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is TherapeuticsMD in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving TherapeuticsMD?

Accepted Answer

Bayer acquires Perfuse Therapeutics (Jun 17, 2026, 7 articles).

Question 8

How did the "Bayer acquires Perfuse Therapeutics" event impact TherapeuticsMD?

Accepted Answer

TherapeuticsMD was acquired by Bayer for an upfront payment of USD 300 million and potential milestone payments up to USD 2.45 billion. It will be fully integrated into Bayer.

Question 9

How did the "BioStem Technologies Appoints New Directors" event impact TherapeuticsMD?

Accepted Answer

Glicko rating system previously served as Chief Executive Officer of TherapeuticsMD, Inc.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.